Healthcare technology company H1 recently announced the acquisition of data management software company Ribbon Health, marking a significant move in the industry. The acquisition, made with a combination of cash and stock, will enhance H1’s offerings and expand its reach into the health plan, provider system, and digital health sectors.
Ribbon Health’s platform plays a crucial role in helping patients find the right healthcare providers across various digital health and insurance platforms. By joining forces with H1, Ribbon Health’s technology will be integrated into H1’s suite of products, now known as H1 for Health Plans and Digital Health. This collaboration will provide insurers, providers, and digital health companies with real-time provider data, ultimately improving the patient experience.
Nate Maslak, founder and CEO of Ribbon Health, expressed excitement about the merger, stating that the combination of their comprehensive provider data and management software with H1’s clinical insights will empower individuals to make informed decisions about their healthcare.
In addition to the acquisition, H1 is refining its product portfolio to better serve the healthcare industry. This includes enhancing AI-powered tools like H1 for Medical, which assists medical affairs teams in identifying and engaging Key Opinion Leaders (KOLs) to promote evidence-based medicine. H1 for Clinical supports clinical teams in identifying sites, principal investigators, and participants for trials, with a focus on diversity, equity, and inclusion. H1 for Commercial streamlines patient access to new medical therapies and technologies.
Furthermore, H1 has welcomed Dr. Stephen Hahn to its Board of Directors. With a background as the former FDA Commissioner and current CEO of Harbinger Health, Dr. Hahn brings valuable expertise in regulatory affairs, clinical research, and healthcare innovation to the company.
H1’s recent accomplishments, including being named one of Forbes’ Best Startup Employers and making the New York Digital Health 100 list, highlight its growing influence in the industry. Supported by investors like Altimeter, Goldman Sachs Asset Management, and Flex Capital, H1 continues to make strides in healthcare technology and data management.
As the company continues to evolve and innovate, Dr. Hahn’s addition to the board underscores H1’s commitment to leveraging data and technology to improve healthcare access and outcomes. With a focus on advancing care and clinical research, H1 is poised to lead the way in driving positive change in the healthcare landscape.
